CLDX vs MYGN
Celldex Therapeutics, Inc. - Common Stock · Myriad Genetics, Inc. - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | CLDX | MYGN |
|---|---|---|
| Price | $29.25 | $5.82 |
| Market Cap | $2.30B | $556.68M |
| P/E | — | — |
| P/B | 3.21 | 1.83 |
| P/S | 1486.72 | 0.68 |
| ROE | -36.2% | -120.4% |
| Net Margin | -16748.0% | -44.4% |
| Gross Margin | — | 69.9% |
| Revenue Growth | -78.0% | -1.6% |
| Dividend Yield | — | — |
| EPS | -$3.30 | -$3.83 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.